Short Report

You have free access to this content

Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly

  1. Kim L. McBride1,3,*,
  2. Elizabeth A. Varga1,3,
  3. Matthew T. Pastore2,3,
  4. Thomas W. Prior4,
  5. Kandamurugu Manickam2,3,
  6. Joan F. Atkin2,3,
  7. Gail E. Herman1,3

Article first published online: 18 MAY 2010

DOI: 10.1002/aur.132

Issue

Autism Research

Autism Research

Volume 3, Issue 3, pages 137–141, June 2010

Additional Information

How to Cite

McBride, K. L., Varga, E. A., Pastore, M. T., Prior, T. W., Manickam, K., Atkin, J. F. and Herman, G. E. (2010), Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res, 3: 137–141. doi: 10.1002/aur.132

Author Information

  1. 1

    Center for Molecular and Human Genetics, Research Institute at Nationwide Children's Hospital, Columbus, Ohio

  2. 2

    Nationwide Children's Hospital, Columbus, Ohio

  3. 3

    Department of Pediatrics, College of Medicine, Ohio State University, Columbus, Ohio

  4. 4

    Department of Pathology, College of Medicine, Ohio State University, Columbus, Ohio

*Center for Molecular and Human Genetics, Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205

Publication History

  1. Issue published online: 23 JUN 2010
  2. Article first published online: 18 MAY 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (147K)

References

  • Abrahams, B.S., & Geschwind, D.H. (2008). Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9, 341–355.
  • Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., & Zoghbi, H.Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23, 185–188.
  • Baker, P., Piven, J., & Sato, Y. (1998). Autism and tuberous sclerosis complex: Prevalence and clinical features. Journal of Autism and Developmental Disorders, 28, 279–285.
  • Butler, M.G., Dasouki, M.J., Zhou, X.P., Talebizadeh, Z., Brown, M., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42, 318–321.
  • Buxbaum, J.D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., et al. (2007). Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 484–491.
    Direct Link:
  • CookJr, E.H., & Scherer, S.W. (2008). Copy-number variations associated with neuropsychiatric conditions. Nature, 455, 919–923.
  • Daly, M.B. (2009). NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian Retrieved December 18, 2009, v.I.2009, from www.nccn.org.
  • Goffin, A., Hoefsloot, L.H., Bosgoed, E., Swillen, A., & Fryns, J.P. (2001). PTEN mutation in a family with Cowden syndrome and autism. American Journal of Medical Genetics, 105, 521–524.
    Direct Link:
  • Han, S.Y., Kato, H., Kato, S., Suzuki, T., Shibata, H., et al. (2000). Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Research, 60, 3147–3151.
  • Hatton, D.D., Sideris, J., Skinner, M., Mankowski, J., BaileyJr., D.B., et al. (2006). Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. American Journal of Medical Genetics Part A, 140A, 1804–1813.
    Direct Link:
  • Herman, G.E., Butter, E., Enrile, B., Pastore, M., Prior, T.W., & Sommer, A. (2007a). Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. American Journal of Medical Genetics Part A, 143, 589–593.
    Direct Link:
  • Herman, G.E., Henninger, N., Ratliff-Schaub, K., Pastore, M., Fitzgerald, S., & McBride, K.L. (2007b). Genetic testing in autism: how much is enough? Genetics in Medicine, 9, 268–274.
  • Lainhart, J.E., Bigler, E.D., Bocian, M., Coon, H., Dinh, E., et al. (2006). Head circumference and height in autism: A study by the Collaborative Program of Excellence in Autism. American Journal of Medical Genetics Part A, 140, 2257–2274.
    Direct Link:
  • Maehama, T., & Dixon, J.E. (1999). PTEN: A tumour suppressor that functions as a phospholipid phosphatase. Trends in Cell Biology, 9, 125–128.
  • Maehama, T., Taylor, G.S., & Dixon, J.E. (2001). PTEN and myotubularin: Novel phosphoinositide phosphatases. Annual Review of Biochemistry, 70, 247–279.
  • Muhle, R., Trentacoste, S.V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 113, e472–486.
  • Ng, P.C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31, 3812–3814.
  • O'Roak, B.J., & State, M.W. (2008). Autism genetics: Strategies, challenges, and opportunities. Autism Research, 1, 4–17.
    Direct Link:
  • Orloff, M.S., & Eng, C. (2008). Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene, 27, 5387–5397.
  • Parisi, M.A., Dinulos, M.B., Leppig, K.A., Sybert, V.P., Eng, C., & Hudgins, L. (2001). The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. Journal of Medical Genetics, 38, 52–58.
  • Schaefer, G.B., Mendelsohn, N.J., & Professional Practice and Guidelines, C. (2008). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genetics in Medicine, 10, 301–305.
  • Sunyaev, S., Ramensky, V., Koch, I., Lathe 3rd, W., Kondrashov, A.S., & Bork, P. (2001). Prediction of deleterious human alleles. Human Molecular Genetics, 10, 591–597.
  • Varga, E.A., Pastore, M., Prior, T., Herman, G.E., & McBride, K.L. (2009). The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genetics in Medicine, 11, 111–117.
  • Zhou, X.P., Waite, K.A., Pilarski, R., Hampel, H., Fernandez, M.J., et al. (2003). Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. American Journal of Human Genetics, 73, 404–411.
  • Zori, R.T., Marsh, D.J., Graham, G.E., Marliss, E.B., & Eng, C. (1998). Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. American Journal of Medical Genetics, 80, 399–402.
    Direct Link:
View Full Article (HTML) Get PDF (147K)